These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10221926)

  • 41. Treatment of high-risk cervical cancer.
    Piver MS
    N Engl J Med; 1999 Aug; 341(9):696-7. PubMed ID: 10475823
    [No Abstract]   [Full Text] [Related]  

  • 42. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
    Morris M; Eifel PJ; Lu J; Grigsby PW; Levenback C; Stevens RE; Rotman M; Gershenson DM; Mutch DG
    N Engl J Med; 1999 Apr; 340(15):1137-43. PubMed ID: 10202164
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [BOMP (BLM, VCR, MMC, and CDDP) therapy for advanced cervical cancer].
    Katayama H; Yamashita T; Sengoku K; Ishikawa M
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():187-91. PubMed ID: 15535231
    [No Abstract]   [Full Text] [Related]  

  • 44. Organ preservation in locally advanced carcinoma of the uterine cervix.
    Smaniotto D; Andrulli AD; Tortoreto F; Niespolo RM; Valentini V
    Rays; 1997; 22(3):472-7. PubMed ID: 9446953
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preliminary evaluation of the use of high dose rate brachytherapy in conjunction with external beam radiation and chemotherapy in the definitive management of cervical carcinoma.
    Boulware RJ; Neglia WJ; Truesdale DW
    J S C Med Assoc; 1996 Jul; 92(7):311-5. PubMed ID: 8764496
    [No Abstract]   [Full Text] [Related]  

  • 46. [Concurrent chemoradiotherapy update].
    Reboul F; Vincent P; Chauvet B; Alfonsi M; Berger C; Serin D
    Bull Cancer; 1999 Jan; 86(1):77-83. PubMed ID: 10029709
    [No Abstract]   [Full Text] [Related]  

  • 47. Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy for women with locally advanced carcinoma of the uterine cervix--final results of a prospective phase II-study.
    Vrdoljak E; Omrcen T; Novaković ZS; Jelavić TB; Prskalo T; Hrepić D; Hamm W
    Gynecol Oncol; 2006 Nov; 103(2):494-9. PubMed ID: 16814371
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Radiochemotherapy versus radiotherapy in locally advanced cervical cancer: a meta-analysis.
    Wang N; Guan QL; Wang K; Zhou X; Gao C; Yang HT; Ni TG
    Arch Gynecol Obstet; 2011 Jan; 283(1):103-8. PubMed ID: 20157716
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lymphoma of uterine cervix.
    Khoury GG; Robinson A
    Eur J Surg Oncol; 1989 Feb; 15(1):65-7. PubMed ID: 2645175
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adjuvant combination chemotherapy in the treatment of advanced cancer of the uterine cervix.
    Chander S; Ghosh D; Aggarwal N
    Indian J Cancer; 1985 Dec; 22(4):266-70. PubMed ID: 2435654
    [No Abstract]   [Full Text] [Related]  

  • 51. Concurrent chemoradiotherapy with paclitaxel and nedaplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: preliminary results of a phase II study.
    Zhang MQ; Liu SP; Wang XE
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):821-7. PubMed ID: 20207507
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pilot study of concurrent cisplatin, 5-fluorouracil, and external beam radiotherapy prior to radical surgery +/- intraoperative electron beam radiotherapy in locally advanced cervical cancer.
    Jurado M; Martínez-Monge R; García-Foncillas J; Azinovic I; Aristu J; López-García G; Brugarolas A
    Gynecol Oncol; 1999 Jul; 74(1):30-7. PubMed ID: 10385548
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
    Rose PG; Bundy BN; Watkins EB; Thigpen JT; Deppe G; Maiman MA; Clarke-Pearson DL; Insalaco S
    N Engl J Med; 1999 Apr; 340(15):1144-53. PubMed ID: 10202165
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Explanation for the failure of neoadjuvant chemotherapy to improve outcomes after radiotherapy for locally advanced uterine cervical cancer from the standpoint of the tumor regression rate.
    Ohara K; Tsunoda H; Tanaka YO; Ohnishi K; Nemoto K; Hashimoto T; Fukumitsu N; Hata M; Sugahara S; Tokuuye K; Yoshikawa H; Akine Y
    Radiat Med; 2007 Feb; 25(2):53-9. PubMed ID: 17541513
    [TBL] [Abstract][Full Text] [Related]  

  • 55. External beam radiotherapy and high-dose brachytherapy combined with cisplatin and paclitaxel in patients with advanced cervical carcinoma.
    Petera J; Odrázka K; Frgala T; Spacek J
    Gynecol Oncol; 2005 Nov; 99(2):334-8. PubMed ID: 16023181
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Radio chemotherapy in carcinoma of the cervix.
    Lorvidhaya V
    Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():221. PubMed ID: 7661585
    [No Abstract]   [Full Text] [Related]  

  • 57. Cardiovascular morbidity after radiotherapy or chemoradiation in patients with cervical cancer.
    Maduro JH; den Dekker HA; Pras E; de Vries EG; van der Zee AG; Klokman WJ; Reyners AK; van Leeuwen FE; Langendijk JA; de Bock GH; Gietema JA
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1337-44. PubMed ID: 20350792
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Does neo-adjuvant chemotherapy have a role in cervical cancer?
    Buxton J; Tobias JS
    Clin Oncol (R Coll Radiol); 1994; 6(6):352-3. PubMed ID: 7873479
    [No Abstract]   [Full Text] [Related]  

  • 59. [Adjuvant chemotherapy in radical surgery of cervix cancer].
    Lahousen M; Haas H; Pickel H
    Gynakol Rundsch; 1989; 29 Suppl 2():372-4. PubMed ID: 2482234
    [No Abstract]   [Full Text] [Related]  

  • 60. Paclitaxel and carboplatin concurrent with radiotherapy for primary cervical cancer.
    de Vos FY; Bos AM; Gietema JA; Pras E; Van der Zee AG; de Vries EG; Willemse PH
    Anticancer Res; 2004; 24(1):345-8. PubMed ID: 15015619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.